James Sulat

James Sulat

Director/Board Member at VALNEVA SE

Net worth: 296 781 $ as of 2026-05-30

75 year
Health Technology
Commercial Services
Consumer Services

Profile

James R.
Sulat
is currently the Vice Chairman at Valneva SE, a Director at Esprit de Corp., and a Director at GS Holdings, Inc. He previously held positions as a Director at Vans, Inc., General Surgical Innovations, Inc., Momenta Pharmaceuticals, Inc., Codexis, Inc., Tolero Pharmaceuticals, Inc., Mallinckrodt Plc, Memory Pharmaceuticals Corp., Ariat International, Inc., AMAG Pharmaceuticals, Inc., Diadexus, Inc., Arch Therapeutics, Inc., and Exicure, Inc. He also served as the Chief Executive & Financial Officer, Director at Maxygen, Inc. and as the Independent Member-Supervisory Board at Intercell AG.
Mr. Sulat has a graduate degree and an MBA from Stanford University, as well as an undergraduate degree from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 97,367 ( 0.05% ) 296 781 $ 2026-05-30

James Sulat active positions

CompaniesPositionStart
VALNEVA SE Director/Board Member 2013-03-06
Director/Board Member -
Director/Board Member 2021-09-30

Former positions of James Sulat

CompaniesPositionEnd
MALLINCKRODT PLC Director/Board Member 2023-11-13
EXICURE, INC. Director/Board Member 2022-12-29
ARCH THERAPEUTICS, INC. Director/Board Member 2021-12-30
AMAG PHARMACEUTICALS, INC. Director/Board Member 2020-11-15
MOMENTA PHARMACEUTICALS, INC. Chairman 2018-05-31
See the detail of James Sulat's experience

Training of James Sulat

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies23

Health Technology

Commercial Services

Distribution Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Consumer Services

Consumer Non-Durables

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance